PET translates neurophysiology into images: A review to stimulate a network between neuroimaging and basic research
暂无分享,去创建一个
Andrea Ciarmiello | Luigi Mansi | A. Ciarmiello | L. Mansi | F. Squitieri | G. Giovacchini | Amalia Milano | A. Milano | Ferdinando Squitieri | Mouna Esmaeilzadeh | Giampiero Giovacchini | M. Esmaeilzadeh
[1] A. Connelly,et al. Longitudinal Quantitative Hippocampal Magnetic Resonance Imaging Study of Adults with Newly Diagnosed Partial Seizures: One‐Year Follow‐Up Results , 1998, Epilepsia.
[2] W. Webb,et al. Neural Activity Triggers Neuronal Oxidative Metabolism Followed by Astrocytic Glycolysis , 2004, Science.
[3] S. DeKosky,et al. Kinetic Modeling of Amyloid Binding in Humans using PET Imaging and Pittsburgh Compound-B , 2005, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[4] E. Courchesne,et al. Attentional Activation of the Cerebellum Independent of Motor Involvement , 1997, Science.
[5] B H Brinkmann,et al. Subtraction SPECT co-registered to MRI improves postictal SPECT localization of seizure foci , 1999, Neurology.
[6] A. Young,et al. A polymorphic DNA marker genetically linked to Huntington's disease , 1983, Nature.
[7] Luigi Mansi,et al. The new FDG brain revolution: the neurovascular unit and the default network , 2010, European Journal of Nuclear Medicine and Molecular Imaging.
[8] L. Cardon,et al. Replication of twelve association studies for Huntington’s disease residual age of onset in large Venezuelan kindreds , 2006, Journal of Medical Genetics.
[9] Alan A. Wilson,et al. Mu‐opiate receptors measured by positron emission tomography are increased in temporal lobe epilepsy , 1988, Annals of neurology.
[10] Leslie G. Ungerleider,et al. Dissociation of object and spatial visual processing pathways in human extrastriate cortex. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[11] M E Raichle,et al. Regional Correction of Positron Emission Tomography Data for the Effects of Cerebral Atrophy , 1988, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[12] M E Phelps,et al. Interictal and postictal focal hypermetabolism on positron emission tomography. , 1993, Pediatric neurology.
[13] M. Jüptner,et al. Review: Does Measurement of Regional Cerebral Blood Flow Reflect Synaptic Activity?—Implications for PET and fMRI , 1995, NeuroImage.
[14] J V Haxby,et al. Low glucose metabolism during brain stimulation in older Down's syndrome subjects at risk for Alzheimer's disease prior to dementia. , 1997, The American journal of psychiatry.
[15] D. Brooks,et al. Striatal D1 and D2 dopamine receptor loss in asymptomatic mutation carriers of Huntington's disease , 1996, Annals of neurology.
[16] L. Sokoloff,et al. Relationships among local functional activity, energy metabolism, and blood flow in the central nervous system. , 1981, Federation proceedings.
[17] Jerry L Prince,et al. Measurement of Radiotracer Concentration in Brain Gray Matter Using Positron Emission Tomography: MRI-Based Correction for Partial Volume Effects , 1992, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[18] J V Haxby,et al. Pattern of cerebral metabolic interactions in a subject with isolated amnesia at risk for Alzheimer's disease: a longitudinal evaluation. , 1993, Dementia.
[19] S. Rapoport,et al. Positron emission tomography in Alzheimer's disease in relation to disease pathogenesis: a critical review. , 1991, Cerebrovascular and brain metabolism reviews.
[20] E. Godaux,et al. Neuronal Deficiency of Presenilin 1 Inhibits Amyloid Plaque Formation and Corrects Hippocampal Long-Term Potentiation But Not a Cognitive Defect of Amyloid Precursor Protein [V717I] Transgenic Mice , 2002, The Journal of Neuroscience.
[21] Gina N. LaRossa,et al. [11C]PIB in a nondemented population , 2006, Neurology.
[22] I. Feinberg,et al. Schizophrenia: caused by a fault in programmed synaptic elimination during adolescence? , 1982, Journal of psychiatric research.
[23] R. Brooks,et al. The role of positron emission tomography in the evaluation of seizure disorders , 1984, Annals of neurology.
[24] Arman Rahmim,et al. Design and Implementation of an Automated Partial Volume Correction in PET: Application to Dopamine Receptor Quantification in the Normal Human Striatum , 2008, Journal of Nuclear Medicine.
[25] Pietro Pietrini,et al. Resting state brain glucose metabolism is not reduced in normotensive healthy men during aging, after correction for brain atrophy , 2004, Brain Research Bulletin.
[26] J. Holzer,et al. Brain Imaging—Applications in Psychiatry , 1991, The Yale Journal of Biology and Medicine.
[27] Louis Sokoloff,et al. Activity‐dependent Energy Metabolism in Rat Posterior Pituitary Primarily Reflects Sodium Pump Activity , 1980, Journal of neurochemistry.
[28] G L Shulman,et al. INAUGURAL ARTICLE by a Recently Elected Academy Member:A default mode of brain function , 2001 .
[29] S. DeKosky,et al. Simplified quantification of Pittsburgh Compound B amyloid imaging PET studies: a comparative analysis. , 2005, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[30] K. Wienhard,et al. MRI-Guided Flumazenil- and FDG-PET in Temporal Lobe Epilepsy , 1996, NeuroImage.
[31] M. Hayden,et al. Homozygosity for CAG mutation in Huntington disease is associated with a more severe clinical course. , 2003, Brain : a journal of neurology.
[32] J. Haxby,et al. Activation of cerebral blood flow during a visuoperceptual task in patients with Alzheimer-type dementia , 1993, Neurobiology of Aging.
[33] R N Gunn,et al. Huntington's disease progression. PET and clinical observations. , 1999, Brain : a journal of neurology.
[34] S. Stone-Elander,et al. D2 dopamine receptors in neuroleptic-naive schizophrenic patients. A positron emission tomography study with [11C]raclopride. , 1990, Archives of general psychiatry.
[35] J. Haines,et al. Effects of Age, Sex, and Ethnicity on the Association Between Apolipoprotein E Genotype and Alzheimer Disease: A Meta-analysis , 1997 .
[36] Stanley I. Rapoport,et al. In vivo PET imaging and postmortem studies suggest potentially reversible and irreversible stages of brain metabolic failure in Alzheimer’s disease , 1999, European Archives of Psychiatry and Clinical Neuroscience.
[37] P. Seeman,et al. Antipsychotic drugs: direct correlation between clinical potency and presynaptic action on dopamine neurons. , 1975, Science.
[38] M. Mintun,et al. Nonoxidative glucose consumption during focal physiologic neural activity. , 1988, Science.
[39] J V Haxby,et al. High-resolution PET studies in Alzheimer's disease. , 1991, Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology.
[40] P. Herscovitch,et al. Cerebral blood flow in temporal lobe epilepsy: a partial volume correction study , 2007, European Journal of Nuclear Medicine and Molecular Imaging.
[41] A. Nordberg. Amyloid plaque imaging in vivo: current achievement and future prospects , 2008, European Journal of Nuclear Medicine and Molecular Imaging.
[42] J. Mazziotta,et al. MRI‐PET Registration with Automated Algorithm , 1993, Journal of computer assisted tomography.
[43] M. Laruelle. Imaging dopamine transmission in schizophrenia. A review and meta-analysis. , 1998, The quarterly journal of nuclear medicine : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology.
[44] W. Klunk,et al. Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound‐B , 2004, Annals of neurology.
[45] W. Gaillard,et al. Neuroimaging and the progression of epilepsy. , 2002, Progress in brain research.
[46] B. de Strooper,et al. Presenilins: members of the gamma-secretase quartets, but part-time soloists too. , 2008, Physiology.
[47] J. Hardy,et al. Is amyloid plaque imaging the key to monitoring brain pathology of Alzheimer’s disease in vivo? , 2004, European Journal of Nuclear Medicine and Molecular Imaging.
[48] N. Andreasen,et al. Hypofrontality in schizophrenia: distributed dysfunctional circuits in neuroleptic-naïve patients , 1997, The Lancet.
[49] R. V. Van Heertum,et al. Prefrontal Dopamine D1 Receptors and Working Memory in Schizophrenia , 2002, The Journal of Neuroscience.
[50] A. Alavi,et al. Ipsilateral and contralateral thalamic hypometabolism as a predictor of outcome after temporal lobectomy for seizures. , 2000, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[51] W. Leslie,et al. Comparison of iodine-123-epidepride and iodine-123-IBZM for dopamine D2 receptor imaging. , 1996, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[52] W. H. Vance,et al. Effects of antidromic stimulation of the ventral root on glucose utilization in the ventral horn of the spinal cord in the rat. , 1987, Proceedings of the National Academy of Sciences of the United States of America.
[53] M. Hayden,et al. The likelihood of being affected with Huntington disease by a particular age, for a specific CAG size. , 1997, American journal of human genetics.
[54] Abraham Z. Snyder,et al. A default mode of brain function: A brief history of an evolving idea , 2007, NeuroImage.
[55] S. DeKosky,et al. Synapse loss in frontal cortex biopsies in Alzheimer's disease: Correlation with cognitive severity , 1990, Annals of neurology.
[56] Richard E Carson,et al. 5-HT 1A receptors are reduced in temporal lobe epilepsy after partial-volume correction. , 2005, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[57] C. Meltzer,et al. Planned Ictal FDG PET Imaging for Localization of Extratemporal Epileptic Foci , 2000, Epilepsia.
[58] Igor Nenadic,et al. Hypofrontality in unmedicated schizophrenia patients studied with PET during performance of a serial verbal learning task , 2000, Schizophrenia Research.
[59] J. Frost. Receptor imaging by PET and SPECT: focus on the opiate receptor. , 1993, Journal of receptor research.
[60] A. Malhotra,et al. Schizophrenia is associated with elevated amphetamine-induced synaptic dopamine concentrations: evidence from a novel positron emission tomography method. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[61] N. Tzourio-Mazoyer,et al. Automated Anatomical Labeling of Activations in SPM Using a Macroscopic Anatomical Parcellation of the MNI MRI Single-Subject Brain , 2002, NeuroImage.
[62] Marc Laruelle,et al. The role of endogenous sensitization in the pathophysiology of schizophrenia: Implications from recent brain imaging studies , 2000, Brain Research Reviews.
[63] J. Hardy,et al. The Amyloid Hypothesis of Alzheimer ’ s Disease : Progress and Problems on the Road to Therapeutics , 2009 .
[64] Andrea Ciarmiello,et al. Brain white-matter volume loss and glucose hypometabolism precede the clinical symptoms of Huntington's disease. , 2006, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[65] Yvette I. Sheline,et al. Potential antecedent marker of Alzheimer disease , 2006 .
[66] W H Theodore,et al. Interictal metabolism and blood flow are uncoupled in temporal lobe cortex of patients with complex partial epilepsy , 1995, Neurology.
[67] Karl J. Friston,et al. Hearing and saying. The functional neuro-anatomy of auditory word processing. , 1996, Brain : a journal of neurology.
[68] R. V. Van Heertum,et al. Increased baseline occupancy of D2 receptors by dopamine in schizophrenia. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[69] S. Petersen,et al. Activation of extrastriate and frontal cortical areas by visual words and word-like stimuli. , 1990, Science.
[70] A. Alavi,et al. False Lateralization of Temporal Lobe Epilepsy with FDG Positron Emission Tomography , 1995, Epilepsia.
[71] J C Mazziotta,et al. Quantifying Interictal Metabolic Activity in Human Temporal Lobe Epilepsy , 1990, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[72] W H Theodore,et al. Hippocampal atrophy, epilepsy duration, and febrile seizures in patients with partial seizures , 1999, Neurology.
[73] G. Bates,et al. Huntingtin aggregation and toxicity in Huntington's disease , 2003, The Lancet.
[74] W. Klunk,et al. Synthesis and evaluation of 11C-labeled 6-substituted 2-arylbenzothiazoles as amyloid imaging agents. , 2003, Journal of medicinal chemistry.
[75] Patrick Kwan,et al. Definition of refractory epilepsy: defining the indefinable? , 2010, The Lancet Neurology.
[76] A. Crane,et al. Differential effects of electrical stimulation of sciatic nerve on metabolic activity in spinal cord and dorsal root ganglion in the rat. , 1985, Proceedings of the National Academy of Sciences of the United States of America.
[77] M. Hayden,et al. The FDG/PET Methodology for Early Detection of Disease Onset: A Statistical Model , 1991, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[78] N C Andreasen,et al. Schizophrenia and cognitive dysmetria: a positron-emission tomography study of dysfunctional prefrontal-thalamic-cerebellar circuitry. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[79] A. Rominger,et al. PET and SPECT in epilepsy: A critical review , 2009, Epilepsy & Behavior.
[80] D. Eidelberg,et al. Metabolic network abnormalities in early Huntington's disease: an [(18)F]FDG PET study. , 2001, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[81] W J Schwartz,et al. Metabolic mapping of functional activity in the hypothalamo-neurohypophysial system of the rat. , 1979, Science.
[82] K. Jellinger,et al. Dopamine uptake sites and dopamine receptors in Parkinson's disease and schizophrenia. , 1990, European neurology.
[83] G. Pearlson,et al. Positron emission tomography reveals elevated D2 dopamine receptors in drug-naive schizophrenics. , 1986, Science.
[84] A H Kaye,et al. MRI-negative PET-positive temporal lobe epilepsy: a distinct surgically remediable syndrome. , 2004, Brain : a journal of neurology.
[85] E. Masliah,et al. Can Alzheimer disease be prevented by amyloid-β immunotherapy? , 2010, Nature Reviews Neurology.
[86] S. Spencer. The Relative Contributions of MRI, SPECT, and PET Imaging in Epilepsy , 1994, Epilepsia.
[87] S. Weinstein,et al. Prognosis of children with partial epilepsy , 2007, Neurology.
[88] D. Ingvar,et al. Absence of activation in frontal structures during psychological testing of chronic schizophrenics. , 1975, Journal of neurology, neurosurgery, and psychiatry.
[89] D. V. van Essen,et al. Retinotopic organization of human visual cortex mapped with positron- emission tomography , 1987, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[90] Leslie G. Ungerleider,et al. A neural system for human visual working memory. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[91] G. Alexander,et al. Functional brain abnormalities in young adults at genetic risk for late-onset Alzheimer's dementia , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[92] R Duncan,et al. Ictal/postictal SPECT in the pre-surgical localisation of complex partial seizures. , 1993, Journal of neurology, neurosurgery, and psychiatry.
[93] D. Weinberger,et al. CEREBELLAR ATROPHY IN CHRONIC SCHIZOPHRENIA , 1979, The Lancet.
[94] E. Ringelstein,et al. Temporal hypometabolism at the onset of cryptogenic temporal lobe epilepsy , 2001, European Journal of Nuclear Medicine.
[95] C. Sherrington,et al. On the Regulation of the Blood‐supply of the Brain , 1890, The Journal of physiology.
[96] J. Krystal,et al. Single photon emission computerized tomography imaging of amphetamine-induced dopamine release in drug-free schizophrenic subjects. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[97] G. Alexander,et al. Regional glucose metabolic abnormalities are not the result of atrophy in Alzheimer's disease , 1998, Neurology.
[98] D J Brooks,et al. Abnormalities of grey and white matter [11C]flumazenil binding in temporal lobe epilepsy with normal MRI. , 2002, Brain : a journal of neurology.
[99] M. D. de Leon,et al. Hypometabolism exceeds atrophy in presymptomatic early-onset familial Alzheimer's disease. , 2006, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[100] C. Jack,et al. Subtraction ictal SPECT co‐registered to MRI improves clinical usefulness of SPECT in localizing the surgical seizure focus , 1998, Neurology.
[101] P B Hoffer,et al. Microdialysis and SPECT measurements of amphetamine‐induced dopamine release in nonhuman primates , 1997, Synapse.
[102] Alberto Pupi,et al. Brain Glucose Hypometabolism and Oxidative Stress in Preclinical Alzheimer's Disease , 2008, Annals of the New York Academy of Sciences.
[103] M. Iyo,et al. Decreased prefrontal dopamine D1 receptors in schizophrenia revealed by PET , 1997, Nature.
[104] J. Haxby,et al. Cholinergic stimulation alters performance and task-specific regional cerebral blood flow during working memory. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[105] M. Buchsbaum,et al. Hypofrontality in schizophrenia as assessed by PET. , 1987, The American journal of psychiatry.
[106] J. Penney,et al. Trinucleotide repeat length instability and age of onset in Huntington's disease , 1993, Nature Genetics.
[107] D. Brooks,et al. Striatal D1 and D2 receptor binding in patients with Huntington's disease and other choreas. A PET study. , 1995, Brain : a journal of neurology.
[108] A. Ciarmiello,et al. Riluzole protects Huntington disease patients from brain glucose hypometabolism and grey matter volume loss and increases production of neurotrophins , 2009, European Journal of Nuclear Medicine and Molecular Imaging.
[109] D E Kuhl,et al. Positron emission tomography measures of benzodiazepine receptors in Huntington's disease , 1993, Annals of neurology.
[110] J. Mazziotta,et al. Presurgical evaluation for partial epilepsy , 1990, Neurology.
[111] M. Mintun,et al. Brain work and brain imaging. , 2006, Annual review of neuroscience.
[112] J C Mazziotta,et al. Tomographic mapping of human cerebral metabolism visual stimulation and deprivation. , 1981, Neurology.
[113] M. Laruelle,et al. Increased dopamine transmission in schizophrenia: relationship to illness phases , 1999, Biological Psychiatry.
[114] P. T. Fox,et al. Positron emission tomographic studies of the cortical anatomy of single-word processing , 1988, Nature.
[115] M. Folstein,et al. EFFECTS OF AGE ON DOPAMINE AND SEROTONIN RECEPTORS MEASURED BY POSITRON TOMOGRAPHY IN THE LIVING HUMAN BRAIN , 1984, Science.
[116] E. Masliah,et al. Can Alzheimer disease be prevented by amyloid-β immunotherapy? , 2010, Nature Reviews Neurology.
[117] M E Raichle,et al. Neuroanatomical circuits in depression: implications for treatment mechanisms. , 1992, Psychopharmacology bulletin.
[118] James A. Scott,et al. Positron Emission Tomography: Basic Science and Clinical Practice , 2004 .
[119] H C Thode,et al. Gamma distribution model describes maturational curves for delta wave amplitude, cortical metabolic rate and synaptic density. , 1990, Journal of theoretical biology.
[120] D. Ingvar,et al. Distribution of cerebral activity in chronic schizophrenia. , 1974, Lancet.
[121] R. Heinrichs. The primacy of cognition in schizophrenia. , 2005, The American psychologist.
[122] W. van Paesschen,et al. Regional hippocampal [11C]flumazenil PET in temporal lobe epilepsy with unilateral and bilateral hippocampal sclerosis. , 1997, Brain : a journal of neurology.
[123] Bryan L Roth,et al. Molecular targets for treating cognitive dysfunction in schizophrenia. , 2007, Schizophrenia bulletin.
[124] Pierre J. Magistretti,et al. Cellular bases of functional brain imaging: insights from neuron-glia metabolic coupling 1 1 Published on the World Wide Web on 12 October 2000. , 2000, Brain Research.
[125] B. Brinkmann,et al. Subtraction peri-ictal SPECT is predictive of extratemporal epilepsy surgery outcome , 2000, Neurology.
[126] Karl Herholz,et al. Metabolic rates in small brain nuclei determined by high-resolution PET. , 2004, Journal of Nuclear Medicine.
[127] J. Haines,et al. Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. APOE and Alzheimer Disease Meta Analysis Consortium. , 1997, JAMA.
[128] I Savic,et al. Comparison of [11C]flumazenil and [18F]FDG as PET markers of epileptic foci. , 1993, Journal of neurology, neurosurgery, and psychiatry.
[129] M. Torrens. Co-Planar Stereotaxic Atlas of the Human Brain—3-Dimensional Proportional System: An Approach to Cerebral Imaging, J. Talairach, P. Tournoux. Georg Thieme Verlag, New York (1988), 122 pp., 130 figs. DM 268 , 1990 .
[130] D J Brooks,et al. Ketone bodies do not directly alter excitatory or inhibitory hippocampal synaptic transmission , 2000, Neurology.
[131] C. Grady,et al. Intercorrelations of regional cerebral glucose metabolic rates in Alzheimer's disease , 1987, Brain Research.
[132] P Pietrini,et al. Cerebral metabolic response to passive audiovisual stimulation in patients with Alzheimer's disease and healthy volunteers assessed by PET. , 2000, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[133] T. Shirao,et al. Loss of proteins regulating synaptic plasticity in normal aging of the human brain and in Alzheimer disease. , 1999, Journal of neuropathology and experimental neurology.
[134] W. Theodore,et al. Complex Partial Seizures: Cerebellar Metabolism , 1987, Epilepsia.
[135] D. Selkoe. Aging, Amyloid, and Alzheimer's Disease: A Perspective in Honor of Carl Cotman , 2003, Neurochemical Research.